Biotechs follow big pharma lead back into academia

被引：0

|

作者：

Jim Kling

机构：

来源：

Nature Biotechnology | 2011年 / 29卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：555 / 556

页数：1

相关论文

共 50 条

[1] Biotechs follow big pharma lead back into academia
Kling, Jim
[J]. NATURE BIOTECHNOLOGY, 2011, 29 (07) : 555 - 556
[2] Correction: Corrigendum: Biotechs follow big pharma lead back into academia
Jim Kling
[J]. Nature Biotechnology, 2012, 30 (1) : 112 - 112
[3] Biotechs follow big pharma lead back into academia (vol 29, pg 555, 2011)
Kling, Jim
[J]. NATURE BIOTECHNOLOGY, 2012, 30 (01)
[4] From academia, to startup, to big pharma, and back again?
Landrum, Gregory
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[5] Biotechs license from big pharma
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2006, 84 (37) : 21 - 21
[6] Biotechs hedge against big pharma givebacks
Emma Dorey
[J]. Nature Biotechnology, 1999, 17 : 416 - 417
[7] BIOTECHS PLATFORM TECHNOLOGIES LURE BIG PHARMA
HODGSON, J
[J]. BIO-TECHNOLOGY, 1995, 13 (09): : 945 - 947
[8] Biotechs hedge against big pharma givebacks
Dorey, E
[J]. NATURE BIOTECHNOLOGY, 1999, 17 (05) : 416 - 417
[9] BIOTECHS, BIG PHARMA IN CANCER DRUG PACTS
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2011, 89 (27) : 13 - 13
[10] Academia and Big Pharma United
Ljunggren, Hans-Gustaf
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (217)

← 1 2 3 4 5 →